The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined With DNA Damage-Inducing or Repair-Compromising Therapies in Preclinical Cancer Models
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-19-0019
Full Text
Open PDFAbstract
Available in full text
Date
October 3, 2019
Authors
Publisher
American Association for Cancer Research (AACR)